Conference Introduction
The opioid use epidemic has been on the forefront of societal concerns in the US. With the DEA-MATE act, all providers must be able to adeptly prescribe and manage Opioid Use Disorder (OUD) and related issues, which have proliferated. Treating teams face multiple challenges including need to treat chronic pain, over prescription of opioids and need for effective alternatives, and illicit use of opioids. The focus of this conference is pharmacological, psychotherapeutic treatments of OUD along with overviews of impact on families and children. We are proud to involve multiple community organizations that provide substance use treatments so attendees can have a comprehensive view of how to get patients effective OUD treatments in and out of the medical system. A main goal for the attendees is to be empowered and confident to initiate and/or maintain treatments for OUD.
Target Audience
Physicians and advanced-practice providers in psychiatry, emergency medicine, family medicine, internal medicine, and obstetrics and gynecology and the community.
Learning Objectives
At the conclusion of the session, the participants should be able to:
Identify and summarize the evolution of the Opioid Epidemic, its impact on our patients, and current needs of our patient population in terms of treatments.
Recognize barriers to accessing medication in treatment of Opioid Use Disorder treatment.
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been designated by Baylor College of Medicine for 0.25 credit of education in pain management and the prescription of opioids.
Available Credit
- 0.25 AMA PRA Category 1 Credit™
- 0.25 Pain Management
- 0.25 Participation